Reassessment of risk factors and long-term results of autologous stem cell transplantation in relapsed and refractory classical Hodgkin lymphoma.

Giancarlo FatobeneCamila da Cruz Gouveia LinardiFrederico MoreiraGabriela Matos Falcão TarguetaFernanda Maria SantosRodrigo Dolphini VelasquesVanderson RochaValeria Buccheri

Published in: Hematological oncology (2019)

Keyphrases

hodgkin lymphoma
stem cell transplantation
risk factors
high dose
bone marrow
platelet rich plasma
low dose
mesenchymal stem cells
acute myeloid leukemia
multiple myeloma